Suppr超能文献

肿瘤异质性:成因与后果

Tumor heterogeneity: causes and consequences.

作者信息

Marusyk Andriy, Polyak Kornelia

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

出版信息

Biochim Biophys Acta. 2010 Jan;1805(1):105-17. doi: 10.1016/j.bbcan.2009.11.002. Epub 2009 Nov 18.

Abstract

With rare exceptions, spontaneous tumors originate from a single cell. Yet, at the time of clinical diagnosis, the majority of human tumors display startling heterogeneity in many morphological and physiological features, such as expression of cell surface receptors, proliferative and angiogenic potential. To a substantial extent, this heterogeneity might be attributed to morphological and epigenetic plasticity, but there is also strong evidence for the co-existence of genetically divergent tumor cell clones within tumors. In this perspective, we summarize the sources of intra-tumor phenotypic heterogeneity with emphasis on genetic heterogeneity. We review experimental evidence for the existence of both intra-tumor clonal heterogeneity as well as frequent evolutionary divergence between primary tumors and metastatic outgrowths. Furthermore, we discuss potential biological and clinical implications of intra-tumor clonal heterogeneity.

摘要

除极少数例外情况外,自发肿瘤起源于单个细胞。然而,在临床诊断时,大多数人类肿瘤在许多形态和生理特征方面表现出惊人的异质性,如细胞表面受体的表达、增殖和血管生成潜力。在很大程度上,这种异质性可能归因于形态和表观遗传可塑性,但也有强有力的证据表明肿瘤内存在基因不同的肿瘤细胞克隆。从这个角度出发,我们总结了肿瘤内表型异质性的来源,重点是基因异质性。我们回顾了肿瘤内克隆异质性以及原发性肿瘤和转移灶之间频繁进化差异存在的实验证据。此外,我们还讨论了肿瘤内克隆异质性的潜在生物学和临床意义。

相似文献

1
Tumor heterogeneity: causes and consequences.
Biochim Biophys Acta. 2010 Jan;1805(1):105-17. doi: 10.1016/j.bbcan.2009.11.002. Epub 2009 Nov 18.
2
[Tumor genetic heterogeneity].
Yi Chuan. 2013 Jan;35(1):1-9. doi: 10.3724/sp.j.1005.2013.00001.
3
Clonal cooperativity in heterogenous cancers.
Semin Cell Dev Biol. 2017 Apr;64:79-89. doi: 10.1016/j.semcdb.2016.08.028. Epub 2016 Aug 28.
4
Breast cancer intra-tumor heterogeneity.
Breast Cancer Res. 2014 May 20;16(3):210. doi: 10.1186/bcr3658.
5
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.
6
A population genetics perspective on the determinants of intra-tumor heterogeneity.
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):109-126. doi: 10.1016/j.bbcan.2017.03.001. Epub 2017 Mar 6.
7
Tumor clonality: research and clinical aspects.
Bull Exp Biol Med. 2014 Dec;158(2):246-51. doi: 10.1007/s10517-014-2733-4. Epub 2014 Nov 30.
8
Intra-tumour heterogeneity: a looking glass for cancer?
Nat Rev Cancer. 2012 Apr 19;12(5):323-34. doi: 10.1038/nrc3261.
9
Intratumor heterogeneity in evolutionary models of tumor progression.
Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15.
10
Intratumor heterogeneity in epigenetic patterns.
Semin Cancer Biol. 2018 Aug;51:12-21. doi: 10.1016/j.semcancer.2018.01.010. Epub 2018 Jan 31.

引用本文的文献

1
DGR-MIL: Exploring Diverse Global Representation in Multiple Instance Learning for Whole Slide Image Classification.
Comput Vis ECCV. 2025;15096:333-351. doi: 10.1007/978-3-031-72920-1_19. Epub 2024 Oct 1.
2
A 3D genome compendium of breast cancer progression.
iScience. 2025 Aug 5;28(9):113268. doi: 10.1016/j.isci.2025.113268. eCollection 2025 Sep 19.
4
Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response.
Genes Dis. 2025 May 8;12(6):101677. doi: 10.1016/j.gendis.2025.101677. eCollection 2025 Nov.
5
Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer.
Front Oncol. 2025 Jul 31;15:1613458. doi: 10.3389/fonc.2025.1613458. eCollection 2025.
8
9
Diagnostic technologies for neuroblastoma.
Lab Chip. 2025 Jul 14. doi: 10.1039/d4lc00005f.
10
Emerging Techniques of Translational Research in Immuno-Oncology: A Focus on Non-Small Cell Lung Cancer.
Cancers (Basel). 2025 Jul 4;17(13):2244. doi: 10.3390/cancers17132244.

本文引用的文献

1
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.
J Clin Invest. 2010 Feb;120(2):636-44. doi: 10.1172/JCI40724. Epub 2010 Jan 25.
2
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
Nature. 2009 Oct 8;461(7265):809-13. doi: 10.1038/nature08489.
3
Irradiation alters selection for oncogenic mutations in hematopoietic progenitors.
Cancer Res. 2009 Sep 15;69(18):7262-9. doi: 10.1158/0008-5472.CAN-09-0604. Epub 2009 Sep 8.
5
Adaptive therapy.
Cancer Res. 2009 Jun 1;69(11):4894-903. doi: 10.1158/0008-5472.CAN-08-3658.
6
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Nat Med. 2009 May;15(5):559-65. doi: 10.1038/nm.1944. Epub 2009 Apr 12.
7
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis.
Nature. 2009 May 21;459(7245):428-32. doi: 10.1038/nature08012. Epub 2009 Apr 12.
8
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers.
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4828-33. doi: 10.1073/pnas.0810276106. Epub 2009 Mar 4.
9
The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress.
FEMS Microbiol Rev. 2009 Jul;33(4):704-17. doi: 10.1111/j.1574-6976.2008.00156.x. Epub 2009 Jan 7.
10
Stem cell concepts renew cancer research.
Blood. 2008 Dec 15;112(13):4793-807. doi: 10.1182/blood-2008-08-077941.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验